In type 2 diabetic mice, endocrine hormone fibroblast growth factor 21 (FGF21) activates CaMKK2/AMPKα, thereby suppressing oxidative stress and enhancing endothelial nitric oxide synthase (eNOS) signalling, improving vessel relaxation [149]. Here, NOS3 is linked to type 2 diabetes mellitus.